Navigation Links
The future of stem cell applications challenging, bright
Date:6/8/2011

An article in the current issue of Technology & Innovation, Proceedings of the National Academy of Inventors reports on the bright future and enormous need for stem cell therapeutics that may offer hope for those suffering from debilitating and deadly diseases.

http://www.ingentaconnect.com/content/cog/ti/2011/00000013/00000001

Stem cell transplantation may offer therapy through "simple cell replacement" procedures to restructure damaged organs, tissues and cells, or provide methods for "reawakening" biological cues to regenerate cells.

"The future for stem cell applications is indeed promising, although there are no assurances that cures will be found," said corresponding author Dr. John Sladek, a professor of the University of Colorado College of Medicine's Departments of Neurology and Pediatrics. "However, there is scientific consensus that time and innovation, combined with a dose of serendipity, will lead to the cures people deserve."

According to Dr. Sladek and co-author Dr. Kimberly Bjugstad, also from the UC Department of Pediatrics, the need for stem cell therapies (based on two categories of stem cells, embryonic stem cells (ESCs), able to differentiate into many kinds of cells (pluripotent), and adult (somatic) stem cells, less capable of high differentiation) - corresponds to many of the diseases most responsible for mortality. The list of potential stem cell therapy targets includes: cardiovascular diseases, cancer, neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, spinal cord injury and autoimmune diseases, including diabetes.

"One of the key, and as yet unanswered questions in cell-based therapeutics, is when in the course of human illness to intervene," said Dr. Sladek. "Traditional wisdom suggests that sooner is better."

Based on their research, Dr. Sladek and his fellow researchers suggest that younger patients with the shortest Parkinson's disease duration, for example, are more suitable for cell transplantations than patients who have suffered with the disease for a decade or longer. The less damaged brain, he said, is more receptive to new cells that function to protect and preserve remaining neurons.

Progress is great, yet scientific challenges to creating new cell-based therapies must be overcome one-by-one.

"Much more is to be learned about reprogramming cells," pointed out Dr. Sladek. "For example, induced pluripotent stem cells (iPSC) are a third source of stem cells. These cells can be reprogrammed in the laboratory to be self-renewing and pluripotent, but in some cases resist reprogramming or retain a genetic memory that may be a complication."

Besides scientific challenges, political challenges to stem cell transplantation persist as well. Despite on-and-off-again bans on federal funding for embryonic stem cell research in the U.S., to the discovery of increasingly more utility in the use of adult stem cells derived from bone marrow, fat cells and liver cells, research in the U.S. is moving forward at great speed as more animal model-based research is leading to human clinical trials.

"It is unlikely that all patients will benefit from cell-based therapies," concluded Dr. Sladek. "Factors related to patient selection need careful consideration, especially concerning stage and severity of disease, the patient's prior therapies, and the need for immunosuppression as well as many other factors."


'/>"/>

Contact: Randolph Fillmore
rfillmore@nasw.org
University of South Florida (USF Health)
Source:Eurekalert

Related medicine news :

1. The future of wireless body area networks is the focus of a June 19-20 workshop at WPI
2. High-fat diet during pregnancy programs child for future diabetes
3. Childhood cancer survivors at higher risk for future GI complications
4. When rising PSA means prostate cancer is in patients future
5. Keck Futures Initiative awards $1 million for 13 research projects
6. Immediate treatment can alleviate future back problems
7. Training future doctors to enlist patients as partners in care
8. Lifesaving antibiotics face doubtful future
9. Starting periods before the age of 10 increases risk of lung complaints in future
10. Depressing future for men?
11. Surgeons predict the future of nanomedicine in practice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... , ... HMP , a leader in healthcare events and education, today announced ... Award for ‘Best B-to-B Healthcare Website.’ Winners were announced during the Eddie & Ozzie ... competition recognizes editorial and design excellence across a range of sectors. This year’s program ...
(Date:10/12/2017)... ... October 12, 2017 , ... On Saturday, October 21, the Health ... Miles by Moonlight to raise money for the American Heart Association Heart Walk. Teams ... Teams will work together to keep their treadmills moving for 5 hours. Treadmills will ...
(Date:10/12/2017)... ... , ... Health Literacy Innovations (HLI), creator of the Health ... Cancer Patient Education Network (CPEN), an independent professional organization that shares best practices ... , As CPEN’s strategic partner, HLI will help support CPEN members by ...
(Date:10/12/2017)... ... October 12, 2017 , ... Vohra Chief Medical ... to physician colleagues, skilled nursing facility medical directors and other clinicians at various ... Wound Care." , "At many of these conferences we get to educate other ...
(Date:10/12/2017)... CHICAGO (PRWEB) , ... October ... ... innovator in life sciences content management, presents its enhanced Pepper Flow promotional ... Oct. 16 -18, 2017. Pepper Flow’s increased insight-driven capabilities help marketers streamline ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... AVACEN Medical , Inc. (AVACEN) announced that ... New Product Innovation Award for Its fibromyalgia pain management ... medical device market research by Frost & Sullivan,s industry experts. ... pain relief product, the AVACEN 100, offers a safe and ... pain. ...
(Date:10/11/2017)... IRVING, Texas , Oct. 11, 2017  Caris ... science focused on fulfilling the promise of precision medicine, ... Institute has joined Caris, Precision Oncology Alliance™ (POA) as ... leading cancer centers, the St. Jude Crosson Cancer Institute ... to advance the use of tumor profiling, making cancer ...
(Date:10/10/2017)... EXTON, Pa. , Oct. 10, 2017   ... leader in innovative solutions for injectable drug administration, today ... of West,s ID Adapter for improving the intradermal administration ... the Fourth Skin Vaccination Summit in May 2017 by ... Team Lead, Polio Department, World Health Organization (WHO), and ...
Breaking Medicine Technology: